Should Sex Be Taken into Account with Left Main Coronary Artery Revascularization?

The EXCEL trial did not find the sex of patients with left main coronary artery disease to be an independent predictor of adverse events after revascularization. However, women who underwent angioplasty had a trend towards worse outcomes, a finding that might be related to comorbidities and somewhat increased chances of peri-procedural complications.

¿Se debe tener en cuenta el género para revascularizar el tronco?In its formal conclusions, this trial tells us that further studies are required to determine the best revascularization strategy in women with complex coronary artery disease. However, these additional studies are unlikely to be conducted in the short or medium term; in consequence, in daily clinical practice, we can make decisions without any regard to sex.

 

All of that comes to dethrone the teachings of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) trial, in which women clearly showed higher mortality rates with angioplasty compared with surgery.


Read also: Differences in Debris Captured According to Valve Type.


The EXCEL (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial, which is more modern, randomized patients with left main disease to angioplasty with everolimus-eluting stent Xience or myocardial revascularization surgery, and followed them for 3 years with a combined endpoint of death, infarction, or stroke.

 

Out of 1905 patients included, 1464 were male (76.9%) and 441 were female (23.1%).

 

These women enrolled were older and had more risk factors (including diabetes) although their coronary lesions were less complex (mean SYNTAX score 24.2 vs. 27.2, p < 0.0001).


Read also: MitraClip in Severe MR: 5 Year Mortality Rate Similar to Surgery.


In a multivariate analysis, sex was not an independent predictor for the primary endpoint (hazard ratio [HR]: 1.10; 95% confidence interval [CI]: 0.82 to 1.48; p = 0.53) or death (HR: 1.39; 95% CI: 0.92 to 2.10; p = 0.12) at 3 years.

 

In the 30-day cut-off, the composite of death, infarction, or stroke occurred in 8.9% of women who underwent angioplasty, 6.2% of women who underwent surgery, 3.6% of men who underwent angioplasty, and 8.4% of men who underwent surgery (p for interaction = 0.003).

 

At 3 years, these differences were mitigated and interactions stopped being significant (p = 0.06) both between men and women, and between revascularization strategies. The numerical differences observed were driven by higher peri-procedural infarction rates in women who underwent angioplasty and by the same event in men who underwent surgery.

 

Original title: Outcomes After Coronary Stenting or Bypass Surgery for Men and Women with Unprotected Left Main Disease. The EXCEL Trial.

Reference: Patrick W. Serruys et al. (J Am Coll Cardiol Intv 2018;11:1234–43).


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...